NFKB1 and subarachnoid hemorrhage: AE also inhibits cell death by reducing the levels of caspase-3, and improves outcomes in subarachnoid hemorrhage by affecting the NF-κB and cyclic adenosine monophosphate/protein kinase A/responsive element-binding protein pathways (Lin et al., 2022).